Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03082 |
| Species: | Homo sapiens |
| Position : | chr17:31209116-31240452 |
| Year: | 2018 |
| Title: | Dissecting super-enhancer hierarchy based on chromatin interactions. |
| Genome Build: | hg19 |
| Enhancer Type: | Super-enhancer |
| Condition: | Normal |
| PMID: | 29507293 |
| Tissue: | blood / hematopoietic system |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Erythroleukemia Cell,B lymphoblastoid Cell |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | TF-binding/chromatin assay; Chromatin interaction assay; Endogenous enhancer perturbation |
| High Throughput Method: | ChIP-seq; Hi-C |
| Low Throughput Method: | CRISPR-Cas9 targeted editing/deletion; ChIP-qPCR/ChIP |
| Target gene : | MYO1D |
| TF name : | EBF1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| EBF1 | Transcriptional regulation of white adipocyte differentiation | reactome | 79 |
| EBF1 | Hs_Tryptophan_metabolism_WP465_85055 | wikipathways | 45 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03083 | chr17:31209116-31240452 | blood / hematopoietic system | malignant cell | NA |
| E_03084 | chr17:31209116-31240452 | blood / hematopoietic system | malignant cell | NA |
| E_03085 | chr17:31209116-31240452 | blood / hematopoietic system | malignant cell | NA |
| E_03086 | chr17:31209116-31240452 | blood / hematopoietic system | malignant cell | NA |
| E_03087 | chr17:31209116-31240452 | blood / hematopoietic system | malignant cell | NA |
| E_03088 | chr17:31209116-31240452 | blood / hematopoietic system | malignant cell | NA |
| E_03089 | chr17:31209116-31240452 | blood / hematopoietic system | malignant cell | NA |